Multibagger Shares

About Manish Goel

SEBI Registered Investment Adviser • Chartered Accountant

454 Articles Published

Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he writes on value-investing principles for education and general awareness.

March 22, 2026

Bar chart of yearly values from FY20 to FY25: FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11 (FY25 bar in green)

Value Traps: Why Cheap Stocks Destroy Wealth

Learn how to identify and avoid value traps — the #1 wealth destroyer in Indian stock markets. Discover the six warning signs, the psychology behind why smart investors fall for them, and how quality compounders like Titan Biotech (50x returns) offer the real path to wealth creation.

March 22, 2026

Hero banner for 'The Peter Lynch Secret' article with subtitle; a 2x2 color grid shows Trader (gray), Compounder (green), Drift (light gray), and Speculator (orange).

The Peter Lynch Secret: How ‘Buy What You Know’ Created India’s Greatest Multibaggers — And Why Most Investors Get It Wrong

📅 Published March 22, 2026 (Sunday) Table of Contents Toggle The Legendary Investor Who Beat Wall Street By Walking Through Shopping Malls What Peter Lynch ACTUALLY […]

March 22, 2026

Bar chart of yearly shares (FY20–FY25) with values 28, 26, 22, 18, 14, 11; FY25 bar is green.

Happy Ugadi & Gudi Padwa 2026! — From Manish Goel & Multibagger Shares

Wishing you a very Happy Ugadi and Gudi Padwa! May this Hindu New Year bring prosperity, wisdom, and wealth to your life and investments.

March 21, 2026

Infographic with a dark blue background showing the headline 'Two Mega Tailwinds for Indian Biotech' and a horizontal bar chart of yearly figures FY20–FY25; bars are purple except FY25, which is green, with values 28, 26, 22, 18, 14, and 11 (FY25). They convey the article's charted data.

Two Mega Tailwinds for Indian Biotech: GLP-1 Drug Patent Expiry + Rupee at ₹94/$ — Why This Is a Golden Moment for Quality Biotech Stocks

📅 Published March 21, 2026 (Saturday) Table of Contents Toggle Two Seismic Developments. One Massive Opportunity. Development #1: GLP-1 Drug Patent Expires in India Development #2: […]